Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 44: 369, 1998;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shaw, L. M.
Right arrow Articles by Oellerich, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Shaw, L. M.
Right arrow Articles by Oellerich, M.
Related Collections
Right arrow Therapeutic Drug Monitoring Conference
Right arrow Drug Monitoring and Toxicology
(Clinical Chemistry. 1998;44:369.)
© 1998 American Association for Clinical Chemistry, Inc.

TDM Conference

The Role of Therapeutic Drug Monitoring in Disease Management: Introduction

Leslie M. Shaw
Michael Oellerich

Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, 3400 Spruce St., Philadelphia, PA 19104
Center for Internal Medicine, Department of Clinical Chemistry, Georg-August University Göttingen, Göttingen, Germany

The following series of papers are based on the accumulated research and practical experience of each author in one or more facets of therapeutic drug monitoring. These papers were the basis for a 2-day program . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the American Association for Clinical Chemistry.